Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine

Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, Roy Kishony
doi: https://doi.org/10.1101/2021.08.29.21262798

Article Information

doi 
https://doi.org/10.1101/2021.08.29.21262798
History 
  • September 1, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Matan Levine-Tiefenbrun1,2,
  2. Idan Yelin1,
  3. Hillel Alapi3,
  4. Rachel Katz3,
  5. Esma Herzel3,
  6. Jacob Kuint2,3,
  7. Gabriel Chodick2,3,
  8. Sivan Gazit3,
  9. Tal Patalon*,3 and
  10. Roy Kishony*,1,4
  1. 1Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel
  2. 2Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  3. 3Maccabitech, Maccabi Health Services, Tel Aviv, Israel
  4. 4Faculty of Computer Science, Technion - Israel Institute of Technology, Haifa, Israel
  1. ↵*corresponding authors. Email: patalon_t{at}mac.org.il, rkishony{at}technion.ac.il.
Back to top
Posted September 01, 2021.
Download PDF
Data/Code
Email
Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, Roy Kishony
medRxiv 2021.08.29.21262798; doi: https://doi.org/10.1101/2021.08.29.21262798
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area